Table 6. Cross-table analysis of efficacy in patients with third- or later line immunotherapy (n=121).
| Parameters | Low ALB, n (%) | High ALB, n (%) | OR (95% CI) | P value |
|---|---|---|---|---|
| ORR | 0.61 | |||
| PD + SD | 51 (83.6) | 48 (80.0) | 1.045 (0.883–1.237) | |
| PR + CR | 10 (16.4) | 12 (20.0) | 0.820 (0.383–1.752) | |
| DCR | 0.05 | |||
| PD | 29 (47.5) | 18 (30.0) | 1.585 (0.993–2.530) | |
| SD + PR + CR | 32 (52.5) | 42 (70.0) | 0.749 (0.560–1.002) |
ALB, albumin; OR, odds ratio; CI, confidence interval; ORR, objective response rate; PD, progressive disease; SD, stable disease; PR, partial response; CR, complete response; DCR, disease control rate.